Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lankester

Showing results (141-150 of 207) with videos related to

Pageof 21
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitutionGertjan Lugthart, Marloes A Oomen, Cornelia M Jol-van der Zijde, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2017
Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric PatientsMatthijs D Kruizinga, Maarten J D van Tol, Vincent Bekker, et al.
Blood Advances|June 7, 2023
Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC studyFederica R Achini-Gutzwiller, Marco W Schilham, Erik G J von Asmuth, et al.
Frontiers in Immunology|March 22, 2019
Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell TransplantationLisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Katrine Kielsen, et al.
Transplantation and Cellular Therapy|October 4, 2021
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter StudyM Y Eileen C van der Stoep, Alice Bertaina, Dirk Jan A R Moes, et al.
Blood Advances|August 19, 2025
RAG1 lentiviral gene therapy restores T cell development of RAG1-SCID patient cells in artificial thymic organoidsXiaolin Meng, Janine E Melsen, Rosalie van der Holst, et al.
Clinical Immunology (Orlando, Fla.)|January 21, 2017
Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infectionsMarjolein Wentink, Virgil Dalm, Arjan C Lankester, et al.
Blood|June 27, 2023
IL-7 receptor signaling drives human B-cell progenitor differentiation and expansionFabian M P Kaiser, Iga Janowska, Roberta Menafra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2014
Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumabLaura Willemsen, Cornelia M Jol-van der Zijde, Rick Admiraal, et al.
Blood|August 31, 2022
A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host diseaseAstrid G S van Halteren, Jessica S Suwandi, Sander Tuit, et al.
Pageof 21

Showing results (141-150 of 207) with videos related to

Sort By:
Pageof 21
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitutionGertjan Lugthart, Marloes A Oomen, Cornelia M Jol-van der Zijde, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2017
Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric PatientsMatthijs D Kruizinga, Maarten J D van Tol, Vincent Bekker, et al.
Blood Advances|June 7, 2023
Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC studyFederica R Achini-Gutzwiller, Marco W Schilham, Erik G J von Asmuth, et al.
Frontiers in Immunology|March 22, 2019
Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell TransplantationLisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Katrine Kielsen, et al.
Transplantation and Cellular Therapy|October 4, 2021
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter StudyM Y Eileen C van der Stoep, Alice Bertaina, Dirk Jan A R Moes, et al.
Blood Advances|August 19, 2025
RAG1 lentiviral gene therapy restores T cell development of RAG1-SCID patient cells in artificial thymic organoidsXiaolin Meng, Janine E Melsen, Rosalie van der Holst, et al.
Clinical Immunology (Orlando, Fla.)|January 21, 2017
Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infectionsMarjolein Wentink, Virgil Dalm, Arjan C Lankester, et al.
Blood|June 27, 2023
IL-7 receptor signaling drives human B-cell progenitor differentiation and expansionFabian M P Kaiser, Iga Janowska, Roberta Menafra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2014
Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumabLaura Willemsen, Cornelia M Jol-van der Zijde, Rick Admiraal, et al.
Blood|August 31, 2022
A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host diseaseAstrid G S van Halteren, Jessica S Suwandi, Sander Tuit, et al.
Pageof 21